Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 4/20 | 0.37 |
| ▸ | SMPD1 | P17405 | 7/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8435577 | 0.93 | L3MBTL1 (0.39) | L3MBTL1CNR2SMPD1BCHEBRD4 | |
| SCHEMBL8431463 | 0.90 | CNR2 (0.39) | L3MBTL1CNR2SMPD1BRD4HIF1A | |
| SCHEMBL10418864 | 0.80 | CA1 (0.42) | CNR2SMPD1 | |
| SCHEMBL10418866 | 0.80 | CA1 (0.42) | CNR2SMPD1 | |
| SCHEMBL8434091 | 0.79 | L3MBTL1 (0.37) | L3MBTL1CNR2HDAC1HDAC2 | |
| SCHEMBL8433658 | 0.79 | SMPD1 (0.44) | CNR2SMPD1HDAC3HDAC1HDAC2 | |
| SCHEMBL10418920 | 0.75 | TLR4 (0.41) | L3MBTL1CNR2BCHE | |
| SCHEMBL8436204 | 0.74 | TLR4 (0.42) | L3MBTL1BCHE | |
| SCHEMBL8436202 | 0.74 | TLR4 (0.42) | L3MBTL1BCHE | |
| SCHEMBL8431552 | 0.74 | L3MBTL1 (0.42) | L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0288888-B1 | Novel glucopyranose derivatives | ONO PHARMACEUTICAL CO (JP) | 1993-12-08 | — | — | EP | disclosed |